TAYSHA GENE THERAPIES INC (TSHA)

US8776191061 - Common Stock

2.46  +0.19 (+8.37%)

After market: 2.46 0 (0%)

Buy % Consensus

81

ChartMill assigns a Buy % Consensus number of 81% to TSHA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.48. This target is 163.29% above the current price.
TSHA was analyzed by 15 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about TSHA.
In the previous month the buy percentage consensus was at a similar level.
TSHA was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 2.462.027.146.489.45 - -17.89% 190.24% 163.29% 284.15%
Up and Down Grades
Date Firm Action Rating
2024-04-19 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-04-18 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-04-11 Needham Reiterate Buy -> Buy
2024-04-09 Piper Sandler Initiate Overweight
2024-03-21 Chardan Capital Maintains Buy -> Buy
2024-03-21 Canaccord Genuity Reiterate Buy -> Buy
2024-03-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-03-20 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-03-20 Needham Maintains Buy -> Buy
2024-02-29 Needham Reiterate Buy -> Buy
2023-12-18 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-11-15 Cantor Fitzgerald Maintains Overweight -> Overweight
2023-09-20 Needham Reiterate Buy -> Buy
2023-09-20 Truist Securities Maintains Buy -> Buy
2023-09-20 Canaccord Genuity Maintains Buy -> Buy
2023-08-16 Canaccord Genuity Maintains Buy -> Buy
2023-08-15 Chardan Capital Reiterate Buy -> Buy
2023-08-15 JMP Securities Reiterate Market Outperform -> Market Outperform
2023-08-15 Needham Maintains Buy -> Buy
2023-08-15 Truist Securities Maintains Buy -> Buy
2023-08-15 Baird Maintains Outperform -> Outperform
2023-08-14 Cantor Fitzgerald Maintains Overweight -> Overweight
2023-07-06 Canaccord Genuity Reiterate Buy -> Buy
2023-06-30 Chardan Capital Reiterate Buy
2023-06-29 Needham Reiterate Buy -> Buy
2023-05-15 Truist Securities Maintains Buy -> Buy
2023-05-12 Needham Reiterate Buy -> Buy
2023-03-30 Chardan Capital Maintains Buy
2023-03-30 Cantor Fitzgerald Maintains Overweight
2023-03-30 JMP Securities Reiterate Market Outperform